Henrik Bisgaard-Frantzen

Title: The Innovations of Henrik Bisgaard-Frantzen

Introduction

Henrik Bisgaard-Frantzen is a notable inventor based in Bagsvaerd, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of alpha-amylase variants and mutants. With a total of 11 patents to his name, his work has had a considerable impact on enzyme technology.

Latest Patents

Among his latest patents are innovations related to alpha-amylase variants. One such invention pertains to a variant of a parent Termamyl-like alpha-amylase, which exhibits altered properties, specifically a reduced capability of cleaving a substrate close to the branching point. This variant also demonstrates improved substrate specificity and/or enhanced specific activity compared to the parent alpha-amylase. Another significant patent involves alpha-amylase mutants, which are variants that maintain alpha-amylase activity while exhibiting alterations in properties such as substrate specificity, substrate binding, substrate cleavage pattern, thermal stability, and pH/activity profile.

Career Highlights

Henrik has worked with prominent companies in the biotechnology sector, including Novozymes A/S. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking innovations in enzyme technology.

Collaborations

Throughout his career, Henrik has collaborated with notable colleagues, including Allan Svendsen and Carsten Schau Andersen. These partnerships have fostered a collaborative environment that has led to significant advancements in their field.

Conclusion

Henrik Bisgaard-Frantzen's contributions to enzyme technology through his patents and collaborations highlight his role as a leading inventor in the biotechnology industry. His work continues to influence the development of innovative solutions in this vital area.